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Recently, regenerative medicine has been focused on as next-generation definitive therapies for several diseases or injuries for 
which there are currently no effective treatments. These therapies have been rapidly developed through the effective fusion be-
tween different fields such as stem cell biology and biomaterials. So far, we have proposed “cell sheet engineering” through our 
core technology that simply applies alterations of the temperature which allows regulation of the attachment or detachment of 
living cells on the culture surfaces grafted with the temperature-responsive polymer “poly(N-isoproplyacrylamide)”. This tech-
nology enables us to construct bioengineered sheet-like tissues, termed “cell sheets”, without the need of using biodegradable 
scaffolds and protease treatments that are traditionally used. Therefore, our carrier-free cell sheets not only are independent of the 
issues observed in conventional methods, but also showed further advantages in the reconstruction of the corneal epithelium or 
endothelium (e.g. improvement of optical transparency and cell-cell interactions to host stroma in reconstructed tissues). Moreo-
ver, our approach does not have issues such as immune rejection or limited number of donors, due to the use of cell sheets derived 
from autologous limbal (in patients with unilateral disease) or oral mucosal epithelial cells (in patients with bilateral disorders). 
Indeed, we have successfully performed the clinical application for the reconstruction of ocular surfaces through the transplanta-
tion of our carrier-free corneal epithelial cell sheets, as evidenced by improved visual acuity as well as long-term maintenance of 
postoperative health conditions on ocular surfaces in all patients. We have also proposed a novel approach for the reconstruction 
of the corneal endothelium using corneal endothelial cell sheets by demonstrating its successful application. Thus, our cell sheet 
engineering technique provides a breakthrough in the field of regenerative medicine applied to the cornea. 
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The eye is a crucial organ to get light information from the 
surrounding environment via its visual performance, and is 
undoubtedly essential to maintain our quality of life. The 
cornea is a transparent tissue, which resides most anteriorly 
in the eye, and is composed of 3 layers (i.e. the epithelial 
layer, stromal layer, and endothelial layer) (Figure 1). The 
layers of the epithelium and endothelium in the cornea are 
mainly composed of only corneal epithelial cells and endo-
thelial cells, respectively. In contrast, the stromal layer con-
tains stromal cells such as keratocytes and massive connec-
tive tissue, including collagen. In fact, the interaction be-
tween these 3 layers accurately governs light refraction in 
the cornea through the maintenance of both its optical 
transparency and thickness, which is critical for image for-
mation at the retina. Therefore, loss of corneal transparency 
by severe diseases or injures induces extremely impaired 
visual performance. To restore corneal transparency in such 
a damaged cornea, transplantation of an allogeneic cornea 
supplied by the Eye Bank has been traditionally performed. 
However, transplantation therapies have been greatly lim-
ited by the serious shortage of donors or immune rejection. 
To fundamentally overcome these issues in transplantation 
medicine, the applications of artificial corneas were previ-
ously attempted as an alternative cure, but have not been  
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Figure 1  Composition of the cornea. The cornea is a transparent tissue 
with a thickness of approximately 0.5 mm.  
established yet.    
Recently, regenerative medicine has been focused on in 
several fields as next-generation treatments for several dis-
eases or injures, for which there is currently no cure. In the 
mid-1980s, transplantations of bioengineered sheet-like 
tissues derived from autologous epidermis to patients with 
severe burns [1], giant congenital nevi [2], or skin ulcers [3] 
were initiated as a therapeutic modality. In addition, based 
on a novel concept termed “tissue engineering”, Langer and 
Vacanti [4–6] were the first to generate a bioengineered ear 
on the back of nude mice using biodegradable scaffolds on 
which chondrocyte were seeded. Subsequently, accompa-
nied with the development of novel biomaterials used as 
carriers or scaffolds, such combinations have contributed to 
the reconstruction of a wide range of tissues (e.g. bone, ar-
teries, blood vessels, and bladders) [7–10].   
In the field of corneal reconstruction, the clinical appli-
cation of regenerative medicine for denatured ocular sur-
faces due to severe trauma (e.g. thermal and chemical burns) 
or eye diseases (e.g. Stevens-Johnson syndrome, ocular 
pemphigoid) was firstly reported by Pellegrini et al. [11] in 
1997. Such injuries or diseases lead to complete loss of 
corneal epithelial stem cells that govern the renewal of the 
corneal epithelium by generating transiently amplifying 
cells, which give rise to severe visual loss with corneal 
vascularization and opacification due to an alternative con-
junctival cover on the corneal stroma [12–14]. Therefore, to 
reconstruct the corneal epithelium accompanied with the 
complementation of corneal epithelial stem cells, they de-
veloped a bioengineered corneal epithelium using autolo-
gous epithelial cells derived from the limbus, the transition 
area between cornea and conjunctiva, where corneal epithe-
lial stem cells are reportedly resided [15,16]. Subsequently, 
for restoration of healthy ocular surfaces in patients, the 
bioengineered tissues were subjected to transplantation of 
the bioengineered corneal epithelium to the naked corneal 
stroma by surgically removing the denatured epithelium, 
following their harvest by treatment with the neutral prote-
ase dispase II. However, in their method, this protease 
treatment induced a weakness of the bioengineered tissues 
because proteins were digested that are involved in cell ad-
hesion or cell-cell junctions at the basal membrane [17,18], 
resulting in extremely difficult manipulation of the grafted 
tissues. In order to overcome such issues, amniotic mem-
branes, collagen, fibrin gels, or gels cross-linked on fibron-
ectin and fibrin have been utilized as carriers of bioengi-
neered corneal epithelium [19–22]. In particular, an amni-
otic membrane, which has a low immunogenic potential as 
well as anti-inflammatory and anti-angiogenic properties, is 
regarded as one of majorly used carriers. However, the use 
of an amniotic membrane leads to decreased adhesion be-
cause the direct association between corneal epithelial cells 
and corneal stroma is interrupted. In addition, the negative 
influence of the permanently presented amniotic membrane 
between the reconstructed epithelium and stroma in the 
cornea cannot be excluded. Bioengineered corneal epithe-
lium using fibrin gels showed improved adhesion between 
the reconstructed tissue and corneal stroma [19]. However, 
in addition to the possibility that the residual fibrin gel neg-
atively influences optical transparency in reconstructed 
cornea, it is important to note that a risk of infection ac-
companied with the use of these biologic materials cannot 
be also excluded. Although there are still several issues that 
need to be overcome, the regenerative medicine for ocular 
surfaces has been steadily progressed and is regarded as one 
of most successful fields in the clinical application of re-
generative medicine. 
Previously, we established a novel method to prepare bi-
oengineered tissues without the use of any carriers or scaf-
folds made from biological materials as well as protease 
treatments, through intelligently modifying the surface of 
culture dishes [23,24]. Our technology addresses the issues 
that arose from the use of biologic materials or protease 
treatments. Here, we introduce our novel concept of “cell 
sheet engineering” and regenerative therapies for corneas 
based on cell sheet engineering. In addition to the treatment 
for ocular surfaces, cell sheet engineering provides also a 
breakthrough in the regenerative therapy for the corneal 
endothelium for which clinical application have not been 
established yet. Consequently, our technology has greatly 
contributed to the progression of the regenerative medicine 
for corneas through the solution of traditional issues as well 
as the merits of carrier-free cell sheets.  
1  Cell sheet engineering based on temperature-    
responsive culture surfaces  
With the concept of tissue engineering based on the combi-
nation of biocompatible or biodegradable materials and liv-
ing cells, the regenerative medicine has made great progress, 
whereas the use of scaffolds makes it very difficult to con-
struct functional tissues with high cell density. Treatments 
with proteases such as dispase can be used for the construc-
tion of sheet-like tissues with high cell density without 
scaffolds, but render the obtained tissues fragile because of 
the digestion of proteins present in cell-cell junctions and 
extracellular matrix (ECM). In order to overcome these is-
sues, we have proposed “cell sheet engineering” as a novel 
method to reconstruct tissues without both biodegradable 
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scaffolds and protease treatments. The core of this approach 
is the application of an intelligent culture surface that is 
covalently-immobilized with a temperature-responsive 
polymer, poly(N-isopropylacrylamide) (PIPAAm). 
PIPAAm shows a hydrophobic character above its lower 
critical solution temperature (LCST: 32°C), but reversely 
obtains a hydrophilic character at temperatures lower than 
32°C through spontaneous conformational changes (Figure 
2(a)). Therefore, the culture dishes on which PIPAAm is 
covalently immobilized at nanometer level thickness enable 
the control of cell adhesion only by temperature alteration 
[24]. In fact, under general conditions of cell culture (37°C: 
above LCST), the temperature-responsive surface shows an 
appropriate hydrophobic status, allowing various types of 
cells to adhere, spread, and proliferate, similar to cells cul-
tured on normal polystyrene culture dishes (Figure 2(b)). In 
contrast, a reduced temperature below the LCST lets the 
culture dish surfaces change to a hydrophilic character, re-
sulting in the detachment of cells by the formation of a hy-
dration layer between the culture dish surface and the at-
tached cells (Figure 2(b)) [24]. Therefore, following the con-
fluent conditions of cultured cells on this intelligent surface, 
low-temperature treatment allows us to obtain sheet-like 
tissues, “cell sheets,” that exhibit high cell density without 
the need of any scaffolds and proteases (Figure 3) [23].  
 
 
Figure 2  (Color online) Change in surface properties on tempera-
ture-responsive culture surfaces by alteration of the temperature. (a) 
Through conformational changes of a temperature-responsive polymer, 
PIPAAm, grafted on culture surfaces, our surfaces show hydrophobic 
properties at 37°C (above LSCT) but hydrophilic properties at 10°C (below 
LSCT). In addition, the wettability changes on temperature-responsive 
surfaces correlated with the surface properties and varied in response to the 
alteration of the temperature. (b) Schematic for the interactions of temper-
ature-responsive surfaces with cells. Conditions above LSCT (e.g. 37°C) 
allow active cell adhesion to the appropriate hydrophobic surfaces of tem-
perature-responsive culture dishes. In contrast, at conditions below LSCT 
(e.g. 20°C), the change to the hydrophilic property in the culture surfaces 
subsequently leads to the detachment of adhered cells.    
Importantly, on the cells within non-invasively obtained cell 
sheets, membrane proteins (e.g. growth factor receptors, ion 
channels, and cell-to-cell junction proteins) are well sus-
tained [18,25]. Therefore, these preserved surface proteins 
contribute to the maintenance of differentiated tissue func-
tions in our carrier-free tissues. In particular, our cell sheets 
with intact cell-to-cell junction proteins and ECM showed a 
significantly enhanced obdurability, compared to those har-
vested after dispase treatment. Furthermore, maintenance of 
the ECM accumulated at the basal side of cells during the 
culture provides an enhanced adhesiveness between our cell 
sheets and other surfaces such as culture dishes and host 
tissues, which is also one of the merits of our cell sheets. So 
far, using temperature-responsive culture surfaces, we have 
established numerous types of carrier-free cell sheets de-
rived from epidermal keratinocytes [18], renal epithelial 
cells [26,27], periodontal ligaments [28,29], retinal pigment 
epithelium [30], Thyroid cells [31], periosteal cells [32], 
cardiomyocytes [33,34] and oral mucosal epithelial cells 
[35,36]. In addition, we demonstrated that multilayered cell 
sheets enable the construction of 3-dimensional tissues with 
much higher cell density compared to the traditional way 
using biodegradable scaffolds [37–39].   
On the other hand, temperature-responsive culture sur-
faces have been developed through the improvement of the 
way for the polymerization of N-isopropylacrylamide 
(IPAAm) or the immobilization of PIPAAm. We originally 
developed temperature-responsive cell culture surface using 
electron-beem induced polymerization methods [40]. Other 
groups reported that plasma activation and plasma poly- 
merization were also available for the surface modification 
with PIPPAm [41]. Recently, to precisely control chain 
length and density of grafted PIPAAm on the surfaces, atom 
transfer radical polymerization (ATRP) or reversible addi-
tion-fragmentation chain transfer (RAFT) polymerization 
are also used, which contributes to enhanced handling of  
 
 
Figure 3  (Color online) Cell sheets are harvested from tempera-
ture-responsive culture surfaces by low-temperature treatment. (a) With 
traditional proteolytic harvest methods (e.g. trypsin or dispase), cells are 
detached, which is accompanied by disruption of both ECM and 
cell-to-cell junction proteins. (b) After the cultured cells became confluent 
on temperature-responsive dishes, cells can be non-invasively harvested as 
intact sheets with their deposited ECM maintained, by simple temperature 
reduction. 
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cell attachment or detachment [42–46]. Furthermore, we 
have also developed the method to fabricate a cell sheet 
using the thermoresponsive surfaces that are prepared via a 
spin-coating method with a block copolymer consisting of 
PIPAAm and poly(butyl methacrylate) (PBMA) on poly-
styrene surfaces [47].  
In addition, we have successfully demonstrate an affinity 
modification between cells and the culture surfaces using 
PIPAAm modified with cell adhesive peptide, without af-
fecting cell detachment by thermal trigger [48]. Furthermore, 
the combination with micropatterning technology enables to 
develop cell sheets with well-controlled orientational struc-
tures [49,50] and vascularized tissue grafts [51,52]. 
Therefore, our novel technology based on temperature- 
responsive culture surfaces overcomes the issues induced by 
the use of proteases, biologic materials-based carrier, or 
biodegradable scaffolds, and greatly contributes to the con-
struction of bioengineered tissues that are clinically safe and 
maneuverable in a wide range of applications in regenera-
tive medicine.   
2  Reconstruction of the corneal epithelium 
With regard to treatments for patients with deficiency of 
corneal epithelial stem cells, it has been generally proposed 
that complementation of the alternative stem cell source is 
indispensable for the restoration of a healthy cornea. Tradi-
tionally, such patients were subjected to transplantation of 
limbal tissues derived from donor eyes as a source of stem 
cells [53,54]. However, limitation of donor materials and 
the high risk of immune rejection remain inescapable. Re-
generative therapies for ocular surfaces are usually based on 
the transplantation of a bioengineered corneal epithelium 
derived from autologous limbal epithelial cells that contain 
stem cells, which addresses the concerns on limited donors 
or immune rejection. However, bioengineered tissues using 
biologic carriers or proteases treatment give rise to several 
issues related to the risk of infections, residual carriers,   
and fragile constructions as described above. Therefore,      
to overcome these issues, we have constructed carrier-     
free bioengineered corneal epithelium without protease   
treatments and biologic carriers using our temperature-     
responsive culture surfaces [17]. In our method, as source of 
autologous corneal epithelial stem cells for patients with 
unilateral disease, a small biopsy sample that can be ob-
tained from the limbus of the healthy eye has been utilized 
(Figure 4), similar to the previous study [11]. Following the 
expansion of autologous limbal epithelial cells on our gen-
erated surface, carrier-free cell sheets could be easily ob-
tained only by low-temperature treatment and were directly 
transplanted to the corneal stroma from which the denatured 
epithelium has been removed. When the cell sheet was 
transferred during the transplantation, it showed superior 
manipulation capability compared to protease-treated 
 
Figure 4  (Color online) Reconstruction of the corneal epithelium by 
using cell sheet engineering. From small biopsy samples of the limbus or 
oral mucosa, epithelial stem cells can be isolated and expanded on temper-
ature-responsive culture surfaces. At the time of surgery, the fabricated 
epithelial cell sheets can be harvested by temperature reduction to 20°C for 
30 min and transplanted directly to the host corneal stroma without the use 
of sutures. 
tissues, which was due to enhanced obdurability achieved 
by preservation of the cell-cell junction or ECM [17]. In 
addition, the intact ECM on the basal side of cells in the cell 
sheets contributed to the rapid and stable attachment to the 
host corneal stroma, allowing stable transplantation of cor-
neal epithelial cell sheets without the need of sutures [17]. 
Furthermore, it is important to note that our carrier- free cell 
sheets showed enhanced optical transparency compared to 
the bioengineered corneal epithelium using amniotic mem-
branes or fibrin gels [17]. Thus, with regard to transplanta-
tion therapies for ocular surfaces, our technology not only 
contributes to overcoming traditional issues, but also pro-
vides the merits of carrier-free cell sheets harvested without 
protease-treatments. 
However, such an advanced regenerative therapy is not 
available for patients with bilateral total limbal stem-cell 
deficiencies, because the limbus cannot be used as a cell 
source for bioengineered tissues. Corneal disorders induced 
by genetic or immune abnormalities lead to bilaterally cor-
neal opacification in most of cases. Therefore, we focused 
on epithelial stem cells derived from oral mucosa as an al-
ternative to limbal epithelial cells used in the autologous 
regenerative therapy of ocular surfaces (Figure 4). In fact, 
bioengineered tissues derived from oral mucosal epithelial 
cells showed similar optical transparency compared to the 
corneal epithelium and were available for transplantation to 
a rabbit corneal model [55]. Moreover, the substitution of 
limbal epithelial cells by oral mucosal epithelial cells is also 
supported by the histological observation that human oral 
mucosal cell sheets recapitulated a structure comparable to 
that of the native corneal epithelium [36]. Interestingly, in 
an animal model of corneal surface reconstruction, follow-
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ing the transplantation, oral mucosal epithelial cell sheets 
resembled an expression pattern of keratin similar to that of 
native corneal epithelial cells rather than native oral muco-
sal epithelial cells [56]. This phenotypic transformation of 
oral mucosal epithelial cells on the corneal stroma indicates 
further that these cells have the potential to be used as an 
appropriate substitution of limbal epithelial cells, and sug-
gests that the interaction with corneal epithelial cells in the 
corneal stroma plays a key role in the maintenance of their 
phenotype. Therefore, our carrier-free system seems to have 
only a minor effect on such interactions, which may con-
tribute to the long-maintenance of healthy conditions in 
transplanted cell sheets. In fact, our clinical trials using au-
tologous oral mucosal cell sheets prepared using tempera-
ture-responsive culture surfaces have demonstrated signifi-
cant improvement in visual acuity and successful long-term 
maintenance of healthy conditions at the ocular surface in 
all patients after transplantation (Figure 5) [36]. In addition, 
we recently established more optimized culture conditions 
in the preparation of cell sheets [57–59] and the validation 
system for tissue-engineered cell sheets [60,61]. Moreover, 
we also developed an autologous transplantation technique 
for patients with inherited corneal disorders by genetic 
modification of corneal epithelial stem cell sheets using 
lentiviral vectors [62]. On the one hand, we have demon-
strated novel findings regarding epithelial cell biology, 
which may contribute to effective preparation of trans-
plantable epithelial cell sheets [63–67]. Thus, we have fur-
ther developed an application in regenerative medicine for 
ocular surfaces through using our technology and optimiz-
ing its associated technologies.  
3  The reconstruction of corneal endothelium  
The native corneal endothelium, a single-cell layer com-
posed of corneal endothelial cells, resides in the proximally 
posterior surface of the corneal stroma, and plays a crucial 
role in the control of hydration and thickness of the stroma 
via both their ATP-dependent endothelial pumps (pump 
function) and focal tight junctions (barrier function), which 
is indispensable for the maintenance of visual acuity [68]. 
However, unlike corneal epithelial cells, human corneal 
endothelial cells are hardly capable of cell proliferation in 
vivo [69,70]. Therefore, the loss of cells in the corneal en-
dothelium is complemented through lateral expansion in 
cell size by residual corneal endothelial cells, and a further 
decrease in the cell number leads to corneal endothelial 
dysfunction, resulting in the occurrence of corneal stromal 
edema [71]. Given these properties or functions in the cor-
neal endothelium, we thought that our carrier-free system 
should be exploited in the reconstruction of the corneal en-
dothelium, because there is only little interruption between 
our cell sheets and the corneal stroma. In addition, human  
 
Figure 5  Eyes of patients before and after transplantation of sheets of 
tissue-engineered autologous epithelial cells. These photographs were 
taken just before transplantation of the cell sheets and postoperatively after 
more than 13 months. Reprinted with permission from [36], © 2004 Mas-
sachusetts Medical Society. All rights reserved. 
corneal endothelial cells reportedly gain the potential for 
cell proliferation under optimized culture conditions in vitro 
[72–74], which enabled us to develop transplantable corneal 
endothelial cell sheets by using a technology that is based 
on temperature-responsive culture surfaces [75,76]. Fur-
thermore, to establish a functional, bioengineered corneal 
endothelium, it is essential to ensure sufficient cell density 
in the prepared cell sheets. Therefore, in order to achieve 
the cell density that is observed in the healthy corneal en-
dothelium (approximately 3000 cells/mm2), corneal endo-
thelial cells were expanded under appropriate conditions by 
using the explant culture and seeded onto temperature-  
responsive culture surfaces at high density [75,76]. Subse-
quently, low-temperature treatment allowed us to obtain 
corneal endothelial cell sheets that recapitulated the struc-
tural and morphological characteristics observed in the na-
tive corneal endothelium, which is a single-cell layer com-
posed of polygonal cell with both microvilli and cilia on the 
apical side of the cell surface. Even though it is a single-cell 
layer, corneal endothelial cell sheets show sufficient 
strength to be grasped using tweezers during the harvest, 
probably because of the preservation of deposited ECM, e.g. 
fibronectin and collagen IV [76]. Importantly, non-invasive 
harvest of cell sheets revealed maintenance of functional 
tight junctions as well as Na+ and K+ ATPase on cells within 
cell sheets [76], which play essential roles in their barrier 
and pump function, respectively. Indeed, our human corneal 
endothelial cell sheets exhibited a great potential for future 
clinical application, as evidenced by the observation that 
direct transplantation of the cell sheets to the stroma of the 
cornea with corneal endothelial dysfunction significantly 
improved corneal stromal hydration and swelling in a rabbit 
model (Figure 6) [75]. Although our proposed regenerative 
therapy for the corneal endothelium certainly demonstrated 
a great healing effect, cell sources for bioengineered corneal  
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Figure 6  Functional corneal endothelial cell sheets. (a) Average corneal 
thickness was measured after transplantation. Control corneas (red circles); 
corneas receiving human corneal endothelial cell sheet transplantation 
(blue squares). Data represent the mean ± SD and a *P-value of less than 
0.05 was considered significant. (b) Slit lamp microscopy 7 d after surgery 
shows that the rabbit corneas receiving human corneal endothelial cell 
sheets were considerably more transparent, with reduced swelling. (c) 
Surface micrographs prior to transplantation show that DiI-labeled corneal 
endothelial cells are present within the tissue-engineered sheets at a similar 
density to that of the native corneal endothelium. (d) The 7 d after trans-
plantation, DiI-derived red fluorescence is still observed at a high density 
in the corneas receiving corneal endothelial cell sheet transplantation. (e) 
Cryosections also show that the DiI-labeled corneal endothelial cell sheets 
remain stably attached to and survive beneath the corneal stroma. (f) He-
matoxylin and eosin staining shows that the corneal endothelial cell sheets 
attach stably to the host stroma and there is decreased stromal swelling and 
cell infiltration in the corneal endothelial cell transplant group. Reprinted 
with permission from [75], © 2006 Federation of American Societies for 
Experimental Biology. 
endothelial cell sheets have been hardly established so far. 
Unlike the corneal epithelium, ectopic cells that can serve as 
a functional alternative to corneal endothelial cells have not 
been identified yet. In addition, it is very difficult to per-
form a biopsy from the healthy eye safely. Therefore, in-
duced pluripotent stem (iPS) cells are currently regarded as 
the most promising candidate for a cell source, whereas the 
clinically applicable way for differentiation of iPS to corne-
al endothelial cells has not been fully established yet. Thus, 
since our proposed therapies seem to be technically availa-
ble for clinical application, the establishment of a safe cell 
source is indispensable to achieve further breakthroughs in 
the application of regenerative medicine for the corneal en-
dothelium. 
4  Conclusion 
In the regenerative medicine for corneal epithelium, our 
technology based on temperature-responsive culture surfac-
es contributes to the solution of several issues observed in 
the traditional treatments (e.g. the risk of infections, residual 
carriers, and fragile constructions). Furthermore, in addition 
to patients with unilateral disorder, our advanced therapies 
have been available for patients with bilateral corneal 
stem-cell deficiencies by the use of autologous oral mucosal 
epithelial cells as an alternative source of stem cells except 
for limbal epithelial cells [17,36]. Importantly, our corneal 
epithelium cell sheets have enhanced optical transparency 
compared to bioengineered tissues using biologic carriers 
[17]. Furthermore, only marginal effects on the direct inter-
action with corneal stroma in the transplanted cell sheets is 
also one of the merits of our systems, because our previous 
report suggests that interaction with the host’s stromal ker-
atocytes contributes to the maintenance of unique properties 
of corneal epithelial cells [56]. Therefore, these advantages 
seem to be essential for the reconstruction of cornea. Con-
sequently, we believe that our method greatly contributes to 
the progression of regenerative therapies for the corneal 
epithelium, and that our proposed treatments will exhibit a 
global dissemination as a definitive therapy for denatured 
ocular surfaces. 
In addition, for the reconstruction of the corneal endothe-
lium, we have developed carrier-free corneal endothelial 
cell sheets that exhibited significant healing effects in ani-
mal models [75,76]. Given the functions of the corneal en-
dothelium, the advantages of our carrier-free cell sheets 
should be exploited in the reconstruction of the corneal en-
dothelium. However, for the clinical application of regener-
ative therapies for the corneal endothelium, the establish-
ment of a safe cell source for the bioengineered corneal en-
dothelium is indispensable, which is currently considered 
the bottleneck of this therapeutic approach.  
In summary, compared to the traditional techniques that 
use biologic carriers or biodegradable scaffolds, our method, 
which is based on carrier-free cell sheets without protease 
treatments, provides several advantages in a wide range of 
fields. In addition, our method is a further breakthrough in 
the reconstruction of the cornea, where optical transparency 
and interactions between each layer of the cornea are criti-
cal for the restoration of its native functions.   
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